0.11 (-%)
As of Nov 01, 2024
Source:
Cns Pharmaceuticals, Inc. is a clinical pharmaceutical company organizedas a Nevada corporation in July 2017 to focus on the development of anti-cancer drug candidates for the treatment of brain and centralnervous system tumors, based on intellectual property that we license under license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center and own pursuant to a collaboration and asset purchaseagreement with Reata Pharmaceuticals, Inc.
Country | United States |
Headquarters | houston, texas |
Phone Number | 1-800-946-9185 |
Industry | manufacturing |
CEO | John Climaco |
Website | www.cnspharma.com |